CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

8 hedge funds and large institutions have $6.29M invested in Celyad Oncology SA American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
FIG
1
Fortress Investment Group
New York
$6.23M
KI
2
Kapitalo Investimentos
Brazil
$29.8K +$29.8K +31,326 New
Citadel Advisors
3
Citadel Advisors
Florida
$15.3K -$12.7K -13,534 -45%
TSS
4
Two Sigma Securities
New York
$10.6K +$10.6K +11,032 New
National Bank of Canada
5
National Bank of Canada
Quebec, Canada
$3.09K
UBS Group
6
UBS Group
Switzerland
$2.04K -$3.51K -3,663 -63%
Wells Fargo
7
Wells Fargo
California
$546
Morgan Stanley
8
Morgan Stanley
New York
$96 -$17.5K -18,200 -99%
OMC
9
Old Mission Capital
Illinois
-$8.04K -16,319 Closed
Millennium Management
10
Millennium Management
New York
-$5K -10,993 Closed